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Toxoplasma gondii is an intracellular pathogen notable for its ability to establish a stable host-parasite relationship amongst a wide
range of host species and in a large percentage of the human population. Toll-like receptor signaling through MyD88 is a critical
pathway in initiating defense against this opportunistic protozoan and may also be a mediator of pathology during immune
dysfunction. Other MyD88 independent signaling pathways are also involved in the host-parasite interaction. These responses
can be triggered by the parasite itself, but interactions with the intestinal microbiota add additional complexity during enteric
infection.
1.Introduction
Host defense against infection relies upon eﬀective mech-
anisms of pathogen detection coupled with the ability to
discriminate between infectious and noninfectious material.
For the case of Toxoplasma gondii, an intracellular protozoan
with worldwide distribution in humans and animals [1],
recognition of infection elicits a rapid and strong Th1-
polarizedimmuneresponsethatisnecessaryforhostsurvival
and long-term parasite persistence [2]. In the context of
chronic infection, characterized by presence of parasite
cysts in tissues of the central nervous system and skeletal
muscle, IFN-γ-producing CD4+ and CD8+ Tl y m p h o c y t e s
are required to maintain quiescent infection [3, 4]. The most
dramatic evidence underlining this concept is found during
AIDSprogression,wherecystreactivationmayoccurasTcell
numbers decline, often with devastating consequences [5].
Studies spanning the last two decades have established
the importance of IL-12 as an early cytokine steering
immunity to a polarized Th1 response that allows con-
trol of Toxoplasma [6–8]. In the absence of IL-12, mice
rapidly succumb to infection due to overwhelming parasite
replication and tissue destruction. The need for IL-12 to
allow host survival extends into chronic infection [9].
During T. gondii infection, this cytokine is produced most
prominently by dendritic cells, but also macrophages and
neutrophils [7, 10–12]. Each of these cell types is targeted
for invasion during in vivo infection, but whether infected
cellsthemselvesaretriggeredtoproduceIL-12orwhetherthe
cytokine is made by noninfected cells responding to parasite
products is less clear. Regardless, it is also apparent that
production of IL-12 must be tightly controlled to prevent
proinﬂammatory pathology. The cytokine IL-10 is a key
player in downregulating the response to Toxoplasma.T h u s ,
IL-10 knockout mice succumb to infection with kinetics
remarkably similar to IL-12 and IFN-γ gene deleted animals
[13]. However, death in animals lacking IL-10 is associated
with low parasite numbers and overwhelmingly high levels
of IL-12, TNF-α,a n dI F N - γ [13, 14]. While it was originally
thought that IL-10 was produced mainly by cells of the
macrophage lineage, more recent data indicate that Th1 cells
themselves are an important source of this cytokine during
Toxoplasma infection [15].
How these complex and essential responses are initiated
during infection with T. gondii and other microbes has been
of long-standing interest to investigators in the ﬁeld. The
concept that cells of innate immunity use pattern recog-
nition receptors (PRRs) to respond to pathogen-associated
molecular patterns (PAMPs) was introduced by Janeway in
the late 1980’s [26]. Ten years later, Janeway and Medzhitov
discovered Toll-like receptors (TLR), a major family of PRR
[27]. Even though TLRs are structurally similar, they are2 Journal of Biomedicine and Biotechnology
Table 1: Summary of ﬁndings in TLR/MyD88 knockout mice.
Mouse strain Susceptibility Phenotype References
MyD88
−/− Highly susceptible Uncontrolled parasite growth; defective IL-12 production; delayed
emergence of Th1 response
[16, 17]
ICE−/− Normal resistance Normal [18]
TLR11
−/− Intermediate resistance Higher cyst burden; mice are resistant to ileitis during enteric infection [19, 20]
TLR2−/− Intermediate resistance Mice are susceptible under high infectious dose conditions [21]
TLR4−/− Unclear Absence of TLR4 confers resistance to gut pathology; absence of TLR4
results in increased susceptibility to peroral infection
[22, 23]
TLR2x4−/− Intermediate resistance Higher cyst burden in the absence of TLR4 and TLR2; decreased
intestinal pathology during enteric infection
[20, 24]
TLR9−/− Intermediate resistance Deceased gut pathology; increased parasite burden [25]
remarkable in that they recognize an extremely diverse array
of microbial molecules, including proteins, lipids, DNA, and
RNA [28]. Triggering of TLR by microbial ligands plays an
important role in initiating immunity to many pathogens,
including T. gondii.
2. Importance of MyD88-Dependent
Toll-Like Receptor Signalingin
DefenseagainstT. gondii
Initial studies on TLR and their ligands focused on recog-
nition of bacterial and viral molecules such as lipopolysac-
charide and nucleic acids, but it soon became clear that
TLRs were also central players in recognition of protozoan
products and in triggering the immune response to this
group of pathogens [29]. Studies in MyD88 gene knockout
mice ﬁrst suggested the importance of TLR in resistance to
T. gondii [16]. The MyD88 molecule is referred to as the
common adaptor of TLR signaling. This is because almost all
TLRs use this molecule to relay signals in the host cell [30].
Accordingly, genetic inactivation of MyD88 results in loss of
almostallTLRsignaling.TheexceptionsareTLR3andTLR4,
whichuseanotheradaptormoleculecalledToll-IL-1receptor
domain containing adaptor-inducing interferon (TRIF). In
an intraperitoneal mouse injection model absence of MyD88
led to rapid death during infection with the normally low
virulenceME49parasitestrain[16].Mortalitywasassociated
with high parasite numbers and low levels of IL-12 and
IFN-γ. In addition, neutrophil recruitment was found to be
defective in the absence of MyD88, an eﬀect that has been
reported in other infectious disease models using this mouse
strain [31, 32].
More recently, increased susceptibility in the absence of
MyD88 was conﬁrmed in animals undergoing Toxoplasma
infection initiated through the oral route [17]. MyD88 is
most often associated with signaling in innate immune cells,
but there is evidence that cells of adaptive immunity also use
this common adaptor molecule. Thus, studies in bone mar-
row chimera mice showed that T cell expression of MyD88 is
necessary to prevent emergence of toxoplasmic encephalitis
during chronic infection [33]. Although the susceptibility
of MyD88 knockout mice to T. gondii implicates TLR in
recognition of the parasite, this adaptor molecule is also
involved in signaling through receptors for IL-1 and IL-18.
However, mice lacking IL-1β-converting enzyme (ICE), a
molecule that is required to produce bioactive IL-1 and IL-
18, display normal resistance to infection [18]. This is an
important result because it provides strong evidence that
TLR signaling per se is required for resistance to T. gondii
infection.
While results from studies using MyD88
−/− mice argue
for their importance, there is as yet no evidence for a master
TLR that controls the immune response to Toxoplasma.A s
describedfurtherinwhatfollows,aparasiteligandformouse
TLR11 has been identiﬁed. Yet, mice lacking this TLR are
only modestly increased in susceptibility relative to MyD88
knockout animals [19]. Along similar lines, TLR2−/− mice
have been reported to display increased susceptibility to
T. gondii, but this eﬀect is only observed using high inocula
[21]. In a study using TLR2x4−/− mice, the animals survived
infection but were reported to harbor an increase in cyst
number in the brain [24]. Another study suggested that
lack of TLR4 increased susceptibility to enteric infection
[22], although diﬀering results were obtained by others
[23]. Given the molecular complexity of this eukaryotic
pathogen, it is reasonable to propose that Toxoplasma pos-
sesses multiple TLR ligands, such that knockout of any single
TLR has minor eﬀects on host resistance (Table 1). Similar
conclusions have been reached in resistance to Trypanosoma
cruzi and Mycobacterium tuberculosis, where TLR2 and TLR9
cooperate to provide optimal immunity to infection [34, 35].
3.ParasiteTLR Ligands
Two Toxoplasma molecular structures serving as TLR
ligands have been identiﬁed to date. The tachyzoite
surface is uniformly covered with glycosylphosphatidyl
inositol-(GPI-)anchored proteins [36]. Puriﬁcation of par-
asite GPI anchors as well as core glycans and lipid moieties
followed by stimulation of cells cotransfected with plasmids
encoding TLR and NFκB reporter genes revealed that GPI
moieties triggered TLR2 and TLR4 [24, 37]. In macrophages,
this leads to production of TNF-α and upregulation of
major histocompatibility complex class II molecules [38].
Interestingly, fatty acids isolated from the parasite block
TNF-α inducing properties of GPI moieties [39]. This could
possibly be related to the observation that live parasites notJournal of Biomedicine and Biotechnology 3
only do not induce TNF-α but actively suppress its synthesis
during lipopolysaccharide-TLR4 triggering [40].
To date, GPI moieties come closest to serve as bona ﬁde
protozoan PAMP molecules [29]. Thus, in addition to those
from Toxoplasma, GPI anchors isolated from Trypanosoma
cruzi, T. brucei, Leishmania major, L. donovani,a n dPlas-
modium falciparum all possess TLR2- or TLR4-activating
properties [41–44]. In some cases, this promotes protective
responses (L. major, T. cruzi), but in others this may be
an underlying cause of pathology (Plasmodium)[ 45]. Why
parasite GPI would activate TLR whereas (as far as is known)
mammalian GPI do not trigger autoimmune reactions may
relate to the fact that GPI molecules are expressed in great
abundanceonthesurfaceoftheseprotozoanparasitesaswell
as the fact that the ﬁne speciﬁcity of these structures varies
amongst species [46].
A soluble parasite lysate (STAg) prepared by sonica-
tion of tachyzoites followed by high speed centrifugation
is well known for its ability to stimulate dendritic cell
IL-12 production in a manner dependent upon MyD88
[16]. Straightforward biochemical fractionation of the lysate
resulted in identiﬁcation of a parasite proﬁlin as the
MyD88-dependent IL-12-inducing molecule [19]. Interest-
ingly, a proﬁlin molecule with IL-12-inducing properties
wassimultaneouslyidentiﬁedfromtherelatedapicomplexan
protozoan Eimeria [47]. Nevertheless, not all apicomplexan
proﬁlins possess the capacity to trigger IL-12 production,
because P. falciparum proﬁlin has at most only weak IL-12-
inducing activity [48]. For Toxoplasma, TLR11 was identiﬁed
as the host cell receptor for proﬁlin [19]. The TLR11
molecule, expressed in mice but not humans, was originally
implicated in responses to uropathogenic bacteria [49], but
to date T. gondii proﬁlin is the only molecule identiﬁed as a
ligand for this receptor. In addition to triggering host cell IL-
12synthesis,proﬁlinisrequiredforinvasion,revealingadual
role in the host-parasite interaction [48, 50]. Proﬁlin is not a
secreted molecule but rather is expressed in the tachyzoite
cytoplasm. This suggests that triggering of IL-12 synthesis
may be mediated by cells responding to parasite degradation
products rather than infection itself.
The TLR/MyD88 pathway is believed to play a role in
controlling T cell immunodominance [51]. This is because
professional antigen presenting cells such as dendritic cells
can simultaneously process and present antigen as well as
upregulate T cell costimulatory molecules in an MyD88-
d e p e n d e n tm a n n e r .I ns u p p o r to ft h i sm o d e l ,i tw a ss h o w n
that intraperitoneal STAg injection triggered an immun-
odominant CD4+ T cell response to proﬁlin that was depen-
dent upon TLR11 expression and major histocompatability
class II recognition within the same dendritic cell population
[52].
4. Role of TLR/MyD88 in the Gut—WhoIs
Doingthe Driving?
It is well established that during high dose Toxoplasma
infection of certain inbred mice, such as the C57BL/6 strain,
animals develop severe pathology in the small intestine
mediated by proinﬂammatory cytokines [53]. A key role
for IL-10 in preventing this pathology under low dose
infection conditions has been shown using IL-10
−/− mice
[14]. Similar intestinal pathology has been reported in
other species infected with T. gondii, although whether this
occurs in humans is not clear [54]. In several respects,
pathology in the C57BL/6 gut resembles Crohn’s disease
in humans, which is now believed to involve dysregulated
Th1 and Th17 responses in the intestinal mucosa [55–57].
As in inﬂammatory bowel disease in humans, pathology
is associated with changes in the microbiota in the gut.
Whether these changes are the result or the trigger of
pathology is a current area of active interest.
During high dose Toxoplasma infection, gram-negative
bacteria accumulate at sites of intestinal damage, and
bacteria translocate into subepithelial regions of the intestine
[58]. Interestingly, both TLR4 and TLR9 knockout mice
are resistant to parasite-induced damage to the intestinal
mucosa, and this is associated with decreased levels of proin-
ﬂammatory cytokines [23, 25]. In addition, mice depleted of
intestinalﬂorabytreatmentwithbroad-spectrumantibiotics
are resistant to ileal damage triggered by T. gondii [58].
These combined results suggest that TLR-based recognition
of bacteria, rather than sensing of the parasite itself, causes
proinﬂammatory pathology in the intestinal mucosa.
Recent evidence also suggests that under low dose
Toxoplasma infection conditions, the endogenous gut micro-
biota have an adjuvant eﬀect on immunity to the parasite
[20]. Thus, TLR11 knockout mice develop a robust Th1
response during enteric infection, despite being unable to
respond to the IL-12-inducing TGPRF molecule. However,
emergence of Th1 cells associated with protection is defec-
tive in TLR2x4−/− and TLR9−/− mice. Reinforcing these
results, Toxoplasma infection of germ-free mice resulted in
defective IL-12 responses in the intestinal mucosa but this
response was restored by feeding mice with the TLR4 ligand
lipopolysaccharide. Thus, it is possible that during orally
initiated Toxoplasma infection, TLR ligands expressed by the
parasite areless important thanTLR ligands expressed by the
intestinalmicrobiota[20,59].Inthisview,T. gondii infection
would cause localized damage to the intestine, possibly as a
resultoftheinvasiveandcell-lyticnatureoftheparasite.This
would allow translocation of bacteria which would, under
low dose conditions, promote diﬀerentiation of protective
Th1 cells but that, under high dose conditions, and would
lead to fulminant pathology. Nevertheless, it is interesting
to note that TLR11
−/− mice were reported to be resistant
to parasite-induced intestinal pathology, a result suggesting
ar o l ef o rT. gondii TGPRF in addition to the contribution
of TLR4 and TLR9 to intestinal inﬂammation [20, 23, 25]
(Table 1).
5.Immune Recognition andProtective
Immunity without MyD88
While TLR and MyD88-dependent signaling is important in
the host response to T. gondii, it is not the only pathway
for recognition of the parasite. During in vitro infection4 Journal of Biomedicine and Biotechnology
of bone marrow-derived macrophages, cells produce IL-12
independently of MyD88 signaling [60]. Interestingly, there
is a parasite strain speciﬁcity to this eﬀect because high
virulence Type I parasites trigger low level IL-12 production
that does not depend upon MyD88, whereas low virulence
Type II strains induce higher amounts of this cytokine in
partial dependence upon MyD88 [60, 61]. Control of IL-
12 production has been linked to ROP16, a polymorphic
rhoptry kinase that mediates its eﬀects through activation
of signal transducer and activator of transcription (STAT)-3
[62, 63].
During enteric infection, we found that MyD88
−/−
animals display uniform mortality that is associated with
uncontrolled parasite replication and dissemination [17].
Nevertheless, while there is a delay in emergence of Th1 cells,
IFN-γ-producing Th1 cell responses reach normal levels
by one week after infection. We hypothesize that although
MyD88 is required for controlling the parasite, it is not
essential to trigger an adaptive response to the parasite in
this situation. It is possible that in the absence of MyD88,
immunity is triggered by bacterial recognition systems such
as NOD2 that do not involve TLR/MyD88 signaling, or that
non-TLR-based recognition of the parasite itself is suﬃcient
to induce a delayed response.
In an eﬀort to get at these issues and to test whether
MyD88 knockout mice could generate a functionally protec-
tive response, we immunized mice with an avirulent uracil
auxotrophic parasite strain called cps1-1 and challenged with
the virulent RH strain [17, 64]. In this case, immunization
triggered emergence of parasite-speciﬁc Th1 cells and as
predicted the animals were resistant to lethal challenge.
Thus, this appears to be a case where MyD88-independent
recognition of T. gondii results in fully functional adaptive
immunity.
The molecular basis for recognition of Toxoplasma
that does not rely on TLR/MyD88 is currently not clear.
However, the parasite triggers Gi-protein coupled receptors
(GiPCR) leading to release of several chemokines including
CCL17 and CCL22 [65, 66]. One particular chemokine
receptor, CCR5, has been linked to IL-12 production [67].
As described above, the parasite activates STAT3 as well as
STAT6 during invasion. Precisely how this occurs is not
clear, but phosphorylation of these transcription factors
does not require MyD88 (Butcher and Denkers, unpublished
observation).
6. Importance of Human TLR in
Resistance to Toxoplasma
Extensive studies in mice have shown the importance of the
TLR/MyD88 pathway in resistance to a broad range of viral,
bacterial, fungal, and protozoan infections. Nevertheless, the
relevance of this pathway in human host defense is less
clear. A cohort of 9 pediatric patients with inherited MyD88
deﬁciency was found to be susceptible to pyogenic bacterial
infections but was unexpectedly resistant to other infections,
including Toxoplasma [68]. Thus, TLR/MyD88 may play a
more narrow role in human host defense relative to the
major eﬀect of this signaling pathway mouse resistance to
infection. However, another interpretation is that MyD88
deﬁciency results in early lethal susceptibility to infection,
so that patients are therefore simply not available for study.
For the speciﬁc case of Toxoplasma, lack of TLR11 expression
argues that parasite proﬁlin is not a major IL-12-inducing
molecule in humans. Nevertheless, after transfection with
human TLR2, CHO cells respond to derivatives of tachyzoite
GPI molecules, arguing for a possible role of TLR2 in human
infection [24]. Thus, the importance of TLR/MyD88 in
humans for resistance to Toxoplasma and other infections is
still an open question.
7. FutureDirections
The mouse model has been extremely valuable in deter-
mining how the innate and adaptive immune system is
coordinated to provide protection against T. gondii,a n d
how dysfunction in the immune system may lead to
immunopathology and death during infection with this
opportunisticprotozoan.TheTLR/MyD88pathwayisclearly
important in early recognition of infection. Yet, molecular
details of how this occurs, and how, in some circumstances,
the parasite evades detection, are still lacking. By applying
genetic tools that are available to study this parasite, we
can expect signiﬁcant progress in this area in the future.
It will also be important in the future to clarify the basis
of Toxoplasma immune recognition in humans. Working
towards these goals will permit a better understanding of
thisimportanthumanpathogenallowingustodevelopmore
eﬀective strategies to prevent and treat disease.
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